CTAB market seen reaching $391 million by 2033

By AI, Created 12:11 PM UTC, June 03, 2026, /AGP/ – Persistence Market Research projects the global Cetrimonium Bromide market will grow from $264 million in 2026 to $391 million by 2033, driven by demand from personal care, pharmaceuticals, biotechnology and industrial cleaning. The report points to rising demand for high-purity CTAB, sustainability efforts and expansion in emerging markets as key growth factors.

Why it matters: - CTAB demand is growing across multiple industries that rely on surfactants, emulsifiers and antimicrobial ingredients. - The market’s projected rise to US$ 391.0 million by 2033 signals steady expansion for suppliers serving cosmetics, pharma, biotech and industrial cleaning. - Higher demand for 99%+ purity CTAB creates a premium segment with stronger value potential.

What happened: - Persistence Market Research estimates the global Cetrimonium Bromide market will reach US$ 264.0 million in 2026. - The same study projects the market will climb to US$ 391.0 million by 2033. - The forecast implies a 5.8% CAGR from 2026 to 2033. - The report was released in London on June 3, 2026. - The company offered a free sample report and a customized market view.

The details: - CTAB is used in cosmetics and personal care as a conditioning agent, emulsifier and antistatic ingredient. - Hair care formulations, skin creams and personal hygiene products are among the main application areas. - Pharmaceutical and biotechnology users rely on CTAB for DNA extraction, laboratory research and pharmaceutical formulations. - Industrial cleaning and disinfectant products use CTAB for its antimicrobial properties. - High-purity CTAB products, especially 99% and above, are seeing strong demand from research labs, biotech firms and pharmaceutical companies. - The report segments the market by form into powder, liquid, and flakes & granules. - The report segments end users into cosmetics & personal care, home and industrial care, pharmaceutical & biotechnology, and chemicals. - The report splits purity into below 99% and 99% & above. - The report covers North America, Europe, East Asia, South Asia & Oceania, Latin America, and Middle East & Africa. - Named companies in the market include Merck KGaA, Thermo Fisher Scientific Inc., Sigma-Aldrich, Evonik Industries AG, BASF SE, Croda International Plc, Lonza Group AG, Xiamen Pioneer Technology Co., Ltd., Thor GmbH and KiON Group LLC.

Between the lines: - The report frames CTAB as a specialty chemical with broad exposure to consumer, life sciences and industrial demand, which can help smooth demand even if one end market slows. - Sustainability, production efficiency and waste reduction are becoming more important as buyers look for more responsible supply chains. - Emerging markets in Asia-Pacific, Latin America and the Middle East are expected to add growth as industrialization, urbanization and healthcare buildout continue. - Competition appears to be shifting toward product quality, capacity expansion and regional reach rather than price alone.

What’s next: - Manufacturers are likely to keep investing in higher-purity production and process improvements. - Strategic partnerships, acquisitions and capacity expansions are expected to remain common as companies try to strengthen supply and distribution. - Research spending in genomics, proteomics and molecular biology should keep supporting CTAB consumption over the forecast period. - Demand in cosmetics and personal care is likely to remain a core growth driver as premium grooming products gain traction.